We have talked previously on this blog about ongoing efforts by the Administration to reform drug pricing, including efforts to dramatically revamp the way in which health plans and their PBMs (including Medicaid MCOs) negotiate drug discounts. At the state level, PBMs have been under fire in recent years, with several State Medicaid agencies alleging
More Posts
CMS Updates “Settings that Isolate” Guidance for HCBS Waivers, Providing Relief to Farmstead and Lifesharing Communities
Massachusetts Governor Seeks New Tools to Negotiate Rebates
Massachusetts Seeks Bids for Rebates from Select Drug Manufacturers
CMS Issues New Guidance Aimed at Addressing Care for Mental Illness
Subscribe: Subscribe via RSS
Blogs
Firm/Org